14 results
·
20ms
·
Sources: EU EUDAMED, US FDA
PROFESSIONAL BLOOD SAMPLE RETRIEVAL SYSTEM
FDA 510(k)
FDA Class 2
·Clinical Chemistry
PremEco Line set-up wax, 95g
FDA UDI
Merz Dental GmbH·D7091030076·PremEco Line set-up wax, 95g
Humelock Reversed Shoulder
FDA UDI
FX SOLUTIONS·03701037306161·RATCHET HANDLE
Kalitec Special
FDA UDI
Kalitec Direct LLC·B073DRK0300060·Egg Handle, 1.75" Fixed Qtr Sq Cann Imp Crimson
MITEK CUFFTACK
FDA 510(k)
FDA Class 2
·Orthopedic
CELL-CHEX
FDA 510(k)
FDA Class 2
·Hematology
4.5MM VA-LCP CURVED CONDYLAR PLATE/14 HOLE/301MM/RIGHT
FDA Adverse Event
Injury
·SYNTHES GMBH·Product code HRS·April 2, 2013
ACCESS® 2 IMMUNOASSAY SYSTEM
FDA Adverse Event
Malfunction
·BECKMAN COULTER, INC.·Product code JJE·March 25, 2011
8030916-2008-00009
FDA Adverse Event
Other
·Product code FSA·April 3, 2008
MAKOPLASTY® PARTIAL KNEE END EFFECTOR
FDA Adverse Event
Malfunction
·MAKO SURGICAL CORP.·Product code OLO·May 8, 2017
MAKOPLASTY® PARTIAL KNEE END EFFECTOR
FDA Adverse Event
Malfunction
·MAKO SURGICAL CORP.·Product code OLO·July 5, 2016
superDimension Systems AAS00016-xx with Software Version 4.0-4.9. Indicated for use for displaying images of the tracheobronchial tree to aid the physician in guiding endoscopic tools or catheters in the pulmonary tract and to enable marker placement within soft lung tissue. It does not make a diagnosis and is not an endoscopic tool. Not for pediatric use.
FDA Enforcement
Class II
·Terminated·superDimension, Inc·July 18, 2012
OPTETRAK Comprehensive Knee System including OPTETRAK Logic RBK PS Tibial Components (Product Line: 02-012-38-XXXX). NOTE: Information reflects Exactech recall expansion initiated on 02/07/2022.
FDA Enforcement
Class II
·Ongoing·Exactech, Inc.·October 13, 2021
Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Boston Scientific, 4100 Hamline Avenue North, St. Paul, MN 55112-5798 USA. Indicated for patients who are at risk for sudden cardiac death due to ventricular arrhythmias and may require pacing support.
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 23, 2013